Hereditary angioedema (HAE) is a rare genetic disorder that causes episodes of severe swelling throughout your body. It is caused by abnormal immune responses. But unlike allergic swelling, HAE is not ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. There's a lot of latest developments. You ...
The FDA awards Fast Track designation to BW-20805 for hereditary angioedema, a therapy designed to reduce attacks through PKK ...
Hereditary angioedema is a rare genetic disease characterized by severe and unpredictable swelling attacks. NTLA-2002 is an in vivo gene-editing therapy that is based on clustered regularly ...
Possible differential diagnoses for hereditary angioedema (HAE) include acquired angioedema with low C1 inhibitor enzyme (AAE-C1-INH), angiotensin-converting enzyme (ACE) inhibitor-induced angioedema ...
Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.
A single dose of the CRISPR-based gene-editing therapy NTLA-2002 significantly reduced angioedema attacks compared with placebo in patients with hereditary angioedema, according to results from a ...
Staying active is an important component of a healthy lifestyle — it improves heart health, builds strength, and supports mental well-being. For people living with hereditary angioedema (HAE), a rare ...
Data include a concurrent assessment of results collected from PGI and AMRA instruments, insights into clinically meaningful changes in HAE attack symptoms, and support for hierarchical ranking of RAP ...
Angioedema is a rare but potentially life-threatening adverse reaction to ACE inhibitors. Researchers have now conducted a genome-wide association study (GWAS) with more than 1,000 affected ...
Hereditary angioedema (HAE) causes severe soft-tissue swelling when C1 inhibitor (C1-INH) dysfunction increases bradykinin, and added inflammation can worsen episodes. Food triggers vary, but studies ...